BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33222322)

  • 21. Two main mutational processes operate in the absence of DNA mismatch repair.
    Németh E; Lovrics A; Gervai JZ; Seki M; Rospo G; Bardelli A; Szüts D
    DNA Repair (Amst); 2020 May; 89():102827. PubMed ID: 32126497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional mutational signature activities in cancer genomes.
    Timmons C; Morris Q; Harrigan CF
    PLoS Comput Biol; 2022 Dec; 18(12):e1010733. PubMed ID: 36469539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SigProfilerMatrixGenerator: a tool for visualizing and exploring patterns of small mutational events.
    Bergstrom EN; Huang MN; Mahto U; Barnes M; Stratton MR; Rozen SG; Alexandrov LB
    BMC Genomics; 2019 Aug; 20(1):685. PubMed ID: 31470794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of cancer mutational signatures on transcription factor motifs in the human genome.
    Yiu Chan CW; Gu Z; Bieg M; Eils R; Herrmann C
    BMC Med Genomics; 2019 May; 12(1):64. PubMed ID: 31109337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Germline variants and somatic mutation signatures of breast cancer across populations of African and European ancestry in the US and Nigeria.
    Wang S; Pitt JJ; Zheng Y; Yoshimatsu TF; Gao G; Sanni A; Oluwasola O; Ajani M; Fitzgerald D; Odetunde A; Khramtsova G; Hurley I; Popoola A; Falusi A; Ogundiran T; Obafunwa J; Ojengbede O; Ibrahim N; Barretina J; White KP; Huo D; Olopade OI
    Int J Cancer; 2019 Dec; 145(12):3321-3333. PubMed ID: 31173346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accuracy of mutational signature software on correlated signatures.
    Wu Y; Chua EHZ; Ng AWT; Boot A; Rozen SG
    Sci Rep; 2022 Jan; 12(1):390. PubMed ID: 35013428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MutVis: Automated framework for analysis and visualization of mutational signatures in pathogenic bacterial strains.
    Prasanna A; Niranjan V
    Infect Genet Evol; 2021 Jul; 91():104805. PubMed ID: 33689914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exome Sequencing of Pancreatic Acinar Carcinoma Identified Distinctive Mutation Patterns.
    Liu Y; Raimondo M; Wallace MB; Mody K; Stauffer JA; Zhang L; Ji B; Bi Y
    Pancreas; 2021 Aug; 50(7):1007-1013. PubMed ID: 34629449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MutationalPatterns: comprehensive genome-wide analysis of mutational processes.
    Blokzijl F; Janssen R; van Boxtel R; Cuppen E
    Genome Med; 2018 Apr; 10(1):33. PubMed ID: 29695279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Excerno: Using Mutational Signatures in Sequencing Data to Filter False Variants Caused by Clinical Archival.
    Mitchell A; Ruiz M; Yang S; Wang C; Davila JI
    J Comput Biol; 2023 Apr; 30(4):366-375. PubMed ID: 36322906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of 7,815 cancer exomes reveals associations between mutational processes and somatic driver mutations.
    Poulos RC; Wong YT; Ryan R; Pang H; Wong JWH
    PLoS Genet; 2018 Nov; 14(11):e1007779. PubMed ID: 30412573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioinformatic Methods to Identify Mutational Signatures in Cancer.
    Islam SMA; Alexandrov LB
    Methods Mol Biol; 2021; 2185():447-473. PubMed ID: 33165866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testing clonal relatedness of two tumors from the same patient based on their mutational profiles: update of the Clonality R package.
    Mauguen A; Seshan VE; Begg CB; Ostrovnaya I
    Bioinformatics; 2019 Nov; 35(22):4776-4778. PubMed ID: 31198957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MSA: reproducible mutational signature attribution with confidence based on simulations.
    Senkin S
    BMC Bioinformatics; 2021 Nov; 22(1):540. PubMed ID: 34736398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated APOBEC mutational signatures implicate chronic injury in etiology of an aggressive head-and-neck squamous cell carcinoma: a case report.
    Patel J; den Breems NY; Tuluc M; Johnson J; Curry JM; South AP; Cho RJ
    J Med Case Rep; 2021 Apr; 15(1):252. PubMed ID: 33926553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A practical framework and online tool for mutational signature analyses show inter-tissue variation and driver dependencies.
    Degasperi A; Amarante TD; Czarnecki J; Shooter S; Zou X; Glodzik D; Morganella S; Nanda AS; Badja C; Koh G; Momen SE; Georgakopoulos-Soares I; Dias JML; Young J; Memari Y; Davies H; Nik-Zainal S
    Nat Cancer; 2020 Feb; 1(2):249-263. PubMed ID: 32118208
    [No Abstract]   [Full Text] [Related]  

  • 37. Analysis of mutational signatures in C. elegans: Implications for cancer genome analysis.
    Meier B; Volkova NV; Gerstung M; Gartner A
    DNA Repair (Amst); 2020 Nov; 95():102957. PubMed ID: 32980770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Palimpsest: an R package for studying mutational and structural variant signatures along clonal evolution in cancer.
    Shinde J; Bayard Q; Imbeaud S; Hirsch TZ; Liu F; Renault V; Zucman-Rossi J; Letouzé E
    Bioinformatics; 2018 Oct; 34(19):3380-3381. PubMed ID: 29771315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MutSignatures: an R package for extraction and analysis of cancer mutational signatures.
    Fantini D; Vidimar V; Yu Y; Condello S; Meeks JJ
    Sci Rep; 2020 Oct; 10(1):18217. PubMed ID: 33106540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topography of mutational signatures in human cancer.
    Otlu B; Díaz-Gay M; Vermes I; Bergstrom EN; Zhivagui M; Barnes M; Alexandrov LB
    Cell Rep; 2023 Aug; 42(8):112930. PubMed ID: 37540596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.